0001618835-23-000007.txt : 20230203 0001618835-23-000007.hdr.sgml : 20230203 20230203170218 ACCESSION NUMBER: 0001618835-23-000007 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230203 DATE AS OF CHANGE: 20230203 EFFECTIVENESS DATE: 20230203 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Evofem Biosciences, Inc. CENTRAL INDEX KEY: 0001618835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208527075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-472618 FILM NUMBER: 23587018 BUSINESS ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE STREET 2: SUITE 600 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 550-1900 MAIL ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE STREET 2: SUITE 600 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: Neothetics, Inc. DATE OF NAME CHANGE: 20140905 D 1 primary_doc.xml X0708 D LIVE 0001618835 Evofem Biosciences, Inc. 12400 HIGH BLUFF DRIVE, SUITE 600 SAN DIEGO CA CALIFORNIA 92130 (858) 550-1900 DELAWARE Neothetics, Inc. Corporation true Saundra Pelletier 12400 High Bluff Drive, Suite 600 San Diego CA CALIFORNIA 92130 Executive Officer Director Justin File 12400 High Bluff Drive, Suite 600 San Diego CA CALIFORNIA 92130 Executive Officer Gillian Greer 12400 High Bluff Drive, Suite 600 San Diego CA CALIFORNIA 92130 Director Kim Kamdar 12400 High Bluff Drive, Suite 600 San Diego CA CALIFORNIA 92130 Director Tony O'Brian 12400 High Bluff Drive, Suite 600 San Diego CA CALIFORNIA 92130 Director Colin Rutherford 12400 High Bluff Drive, Suite 600 San Diego CA CALIFORNIA 92130 Director Lisa Rarick 12400 High Bluff Drive, Suite 600 San Diego CA CALIFORNIA 92130 Director Jenny Yip 12400 High Bluff Drive, Suite 600 San Diego CA CALIFORNIA 92130 Director Biotechnology Decline to Disclose 06b false 2022-12-20 false true true true false 0 2307693 2307693 0 false 8 0 0 0 false Evofem Biosciences, Inc. /s/ Justin J. File Justin J. File Chief Financial Officer 2023-02-01